Compare · CDNA vs UNH
CDNA vs UNH
Side-by-side comparison of CareDx Inc. (CDNA) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDNA and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $336.47B, about 313.0x CDNA ($1.08B).
- Over the past year, CDNA is up 38.5% and UNH is down 7.4% - CDNA leads by 45.9 points.
- UNH has been more active in the news (22 items in the past 4 weeks vs 17 for CDNA).
- UNH has more recent analyst coverage (25 ratings vs 18 for CDNA).
- Company
- CareDx Inc.
- UnitedHealth Group Incorporated
- Price
- $20.79+0.56%
- $370.58-0.04%
- Market cap
- $1.08B
- $336.47B
- 1M return
- +19.73%
- +36.98%
- 1Y return
- +38.47%
- -7.41%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 17
- 22
- Recent ratings
- 18
- 25
CareDx Inc.
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development and commercialization rights to NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest CDNA
- SEC Form S-3ASR filed by CareDx Inc.
- SEC Form 10-Q filed by CareDx Inc.
- CareDx Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Regulation FD Disclosure, Entry into a Material Definitive Agreement, Other Events
- CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
- CareDx Announces First Quarter 2026 Financial Results
- SEC Form DEFA14A filed by CareDx Inc.
- SEC Form DEF 14A filed by CareDx Inc.
- Amendment: CareDx Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 4 filed by Kennedy Keith
- SEC Form 4 filed by Hanna John Walter Jr
Latest UNH
- New Survey Finds Widespread Mental and Behavioral Health Challenges Among Young Adults and College Students
- Chief Executive Officer, Optum Conway Patrick Hugh sold $284,000 worth of shares (800 units at $355.00), decreasing direct ownership by 4% to 17,805 units (SEC Form 4)
- UnitedHealth upgraded by Erste Group
- UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
- UnitedHealth upgraded by Argus with a new price target
- SEC Form DEFA14A filed by UnitedHealth Group Incorporated
- SEC Form DEF 14A filed by UnitedHealth Group Incorporated
- UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- UnitedHealth Group Reports First Quarter 2026 Results
- UnitedHealthcare Eliminates Most Medical Prior Authorizations, Accelerates Payments for Key Rural Care Hospitals and Providers Nationwide